Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Cash & Equivalents (2016 - 2025)

Glaukos (GKOS) has disclosed Cash & Equivalents for 12 consecutive years, with $90.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 46.46% to $90.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $90.8 million, a 46.46% decrease, with the full-year FY2025 number at $90.8 million, down 46.46% from a year prior.
  • Cash & Equivalents was $90.8 million for Q4 2025 at Glaukos, down from $98.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $169.6 million in Q4 2024 to a low of $42.5 million in Q1 2024.
  • A 5-year average of $101.0 million and a median of $100.8 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 64.86% in 2021, then skyrocketed 168.86% in 2025.
  • Glaukos' Cash & Equivalents stood at $100.7 million in 2021, then rose by 18.68% to $119.5 million in 2022, then decreased by 21.8% to $93.5 million in 2023, then surged by 81.48% to $169.6 million in 2024, then tumbled by 46.46% to $90.8 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's Cash & Equivalents are $90.8 million (Q4 2025), $98.2 million (Q3 2025), and $100.8 million (Q2 2025).